PTC Therapeutics (PTCT) PT Raised on BofA/Merrill Lynch on ex-US Translarna Sales

March 2, 2015 8:07 AM

BofA/Merrill Lynch analyst Tazeen Ahmad reiterated a Buy rating and boosted its price target on PTC Therapeutics (NASDAQ: PTCT) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found